Literature DB >> 20807092

Hepatitis-B reactivation and rituximab-containing chemotherapy: an increasingly complex clinical challenge.

Philip A Thompson1, Constantine S Tam, Karin Thursky, John F Seymour.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20807092     DOI： 10.3109/10428194.2010.509456

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN： 1026-8022


× No keyword cloud information.
  3 in total

1.  Screening for hepatitis B in patients with lymphoma.

Authors:  Jonathan Ramirez; Anupama Thadareddy Duddempudi; Moazzam M Sana; Syed S Hasan; Mario de Los Santos; Juhee Song; Ying Fang-Hollingsworth; Sandeep S Gupta; Dawn M Sears
Journal:  Proc (Bayl Univ Med Cent)       Date:  2015-10

2.  Reactivation of hepatitis B (reverse seroconversion) after melphalan/dexamethasone therapy for primary amyloidosis: a case report.

Authors:  Woo-Ram Moon; Do-Sik Moon; JoA Kim; Young-Min Yoon; Byung-Seok Choi; Choon-Hae Chung; Sang-Gon Park
Journal:  J Med Case Rep       Date:  2015-06-02

3.  Concurrent infection of hepatitis B virus negatively affects the clinical outcome and prognosis of patients with non-Hodgkin's lymphoma after chemotherapy.

Authors:  Jie Chen; Jianmin Wang; Jianmin Yang; Weiping Zhang; Xianmin Song; Li Chen
Journal:  PLoS One       Date:  2013-07-08       Impact factor: 3.240
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.